{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T10:34:03Z","timestamp":1753439643217},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,6,28]],"date-time":"2014-06-28T00:00:00Z","timestamp":1403913600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Brain Struct Funct"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s00429-014-0812-y","type":"journal-article","created":{"date-parts":[[2014,6,27]],"date-time":"2014-06-27T01:27:00Z","timestamp":1403832420000},"page":"3043-3051","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Decrease of mGluR5 receptor density goes parallel with changes in enkephalin and substance P immunoreactivity in Huntington\u2019s disease: a preliminary investigation in the postmortem human brain"],"prefix":"10.1007","volume":"220","author":[{"given":"Bal\u00e1zs","family":"Guly\u00e1s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judit","family":"Sovago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baltazar","family":"Gomez-Mancilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhisheng","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Csaba","family":"Szigeti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K\u00e1roly","family":"Gulya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph Paul","family":"Maguire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Gasparini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christer","family":"Halldin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,28]]},"reference":[{"key":"812_CR1","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/mds.1090","volume":"16","author":"JE Ahlskog","year":"2001","unstructured":"Ahlskog JE, Muenter MD (2001) Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov Disord 16:448\u2013458","journal-title":"Mov Disord"},{"key":"812_CR2","doi-asserted-by":"crossref","first-page":"6467","DOI":"10.1016\/j.bmc.2008.05.039","volume":"16","author":"AJ Airaksinen","year":"2008","unstructured":"Airaksinen AJ, Nag S, Finnema SJ, Mukherjee J, Chattopadhyay S, Guly\u00e1s B, Farde L, Halldin C (2008) [11C]cyclopropyl-FLB 457: a PET radioligand for low densities of dopamine D2 receptors. Bioorg Med Chem 16:6467\u20136473","journal-title":"Bioorg Med Chem"},{"key":"812_CR3","first-page":"698","volume":"47","author":"SM Ametamey","year":"2006","unstructured":"Ametamey SM, Kessler LJ, Honer M, Wyss MT, Buck A, Hintermann S, Auberson YP, Gasparini F, Schubiger PA (2006) Radiosynthesis and preclinical evaluation of 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5. J Nucl Med 47:698\u2013705","journal-title":"J Nucl Med"},{"key":"812_CR4","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/0306-4522(95)00595-1","volume":"72","author":"SJ Augood","year":"1996","unstructured":"Augood SJ, Faull RL, Love DR, Emson PC (1996) Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington\u2019s disease: a detailed cellular in situ hybridization study. Neuroscience 72:1023\u20131036","journal-title":"Neuroscience"},{"key":"812_CR5","doi-asserted-by":"crossref","unstructured":"Berg D, Godau J, Trenkwalder C, Eggert K, Csoti I, Storch A, Huber H, Morelli-Canelo M, Stamelou M, Ries V, Wolz M, Schneider C, Di Paolo T, Gasparini F, Hariry S, Vandemeulebroecke M, Abi-Saab W, Cooke K, Johns D, Gomez-Mancilla B. (2011) AFQ056 treatment of levodopa-induced dyskinesias: results of 2 randomized controlled trials. Mov Disord 26:1243\u20131250","DOI":"10.1002\/mds.23616"},{"key":"812_CR6","doi-asserted-by":"crossref","unstructured":"Canzoniero LMT, Granzotto A, Turetsky DM, Choi DW, Dugan LL, Sensi SL (2013) nNOS(+) striatal neurons, a subpopulation spared in Huntington\u2019s disease, possess functional NMDA receptors but fail to generate mitochondrial ROS in response to an excitotoxic challenge. Front Physiol 16(4):112","DOI":"10.3389\/fphys.2013.00112"},{"key":"812_CR7","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1073\/pnas.95.11.6480","volume":"95","author":"JH Cha","year":"1998","unstructured":"Cha JH, Kosinski CM, Kerner JA, Alsdorf SA, Mangiarini L, Davies SW, Penney JB, Bates GP, Young AB (1998) Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene. Proc Natl Acad Sci USA 95:6480\u20136485","journal-title":"Proc Natl Acad Sci USA"},{"key":"812_CR8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0165-0173(00)00039-4","volume":"34","author":"F Cicchetti","year":"2000","unstructured":"Cicchetti F, Prensa L, Wu Y, Parent A (2000) Chemical anatomy of striatal interneurons in normal individuals and in patients with Huntington\u2019s disease. Brain Res Brain Res Rev 34:80\u2013101","journal-title":"Brain Res Brain Res Rev"},{"key":"812_CR9","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1083\/jcb.25.3.577","volume":"25","author":"JW Combs","year":"1965","unstructured":"Combs JW, Lagunoff D, Benditt EP (1965) Differentiation and proliferation of embryonic mast cells of the rat. J Cell Biol 25:577\u2013592","journal-title":"J Cell Biol"},{"key":"812_CR10","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nrn1763","volume":"6","author":"PJ Conn","year":"2005","unstructured":"Conn PJ, Battaglia G, Marino MJ, Nicoletti F (2005) Metabotropic glutamate receptors in the basal ganglia motor circuit. Nat Rev Neurosci 6:787\u2013798","journal-title":"Nat Rev Neurosci"},{"key":"812_CR11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0006-8993(86)91469-1","volume":"372","author":"D Dawbarn","year":"1986","unstructured":"Dawbarn D, Zamir N, Waters CM, Hunt SP, Emson PC, Brownstein MJ (1986) Peptides derived from prodynorphin are decreased in basal ganglia of Huntington\u2019s disease brains. Brain Res 372:155\u2013158","journal-title":"Brain Res"},{"key":"812_CR12","first-page":"143","volume":"27","author":"YP Deng","year":"2004","unstructured":"Deng YP, Albin RL, Penney JB, Young AB, Anderson KD, Reiner A (2004) Differential loss of striatal projection systems in Huntington\u2019s disease: a quantitative immunohistochemical study. J Chem Anat 27:143\u2013164","journal-title":"J Chem Anat"},{"key":"812_CR13","first-page":"159","volume":"26","author":"MK Dutt","year":"1980","unstructured":"Dutt MK (1980) Method for the demonstration of DNA-phosphate groups and DNA-aldehyde molecules with a basic dye, methylene green. Cell Mol Biol Incl Cyto Enzymol 26:159\u2013163","journal-title":"Cell Mol Biol Incl Cyto Enzymol"},{"key":"812_CR14","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.brainres.2012.03.014","volume":"1453","author":"S Farkas","year":"2012","unstructured":"Farkas S, Nagy K, Jia Z, Hortob\u00e1gyi T, Varrone A, Halldin C, Csiba L, Guly\u00e1s B (2012) Signal transduction pathway activity compensates dopamine D(2)\/D(3) receptor density changes in Parkinson\u2019s disease: a preliminary comparative human brain receptor autoradiography study with [(3)H]raclopride and [(3)(5)S]GTPgammaS. Brain Res 1453:56\u201363","journal-title":"Brain Res"},{"key":"812_CR15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0304-3940(84)90127-7","volume":"49","author":"J Feger","year":"1984","unstructured":"Feger J, Crossman AR (1984) Identification of different subpopulations of neostriatal neurones projecting to globus pallidus or substantia nigra in the monkey: a retrograde fluorescence double-labelling study. Neurosci Lett 49:7\u201312","journal-title":"Neurosci Lett"},{"key":"812_CR16","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0304-3940(86)90634-8","volume":"71","author":"RJ Ferrante","year":"1986","unstructured":"Ferrante RJ, Kowall NW, Richardson EP Jr, Bird ED, Martin JB (1986) Topography of enkephalin, substance P and acetylcholinesterase staining in Huntington\u2019s disease striatum. Neurosci Lett 71:283\u2013288","journal-title":"Neurosci Lett"},{"key":"812_CR17","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1523\/JNEUROSCI.19-04-01189.1999","volume":"19","author":"FR Fusco","year":"1999","unstructured":"Fusco FR, Chen Q, Lamoreaux WJ, Figueredo-Cardenas G, Jiao Y, Coffman JA, Surmeier DJ, Honig MG, Carlock LR, Reiner A (1999) Cellular localization of huntingtin in striatal and cortical neurons in rats: lack of correlation with neuronal vulnerability in Huntington\u2019s disease. J Neurosci 19:1189\u20131202","journal-title":"J Neurosci"},{"key":"812_CR18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coph.2009.10.010","volume":"10","author":"K Fuxe","year":"2010","unstructured":"Fuxe K, Marcellino D, Leo G, Agnati LF (2010) Molecular integration via allosteric interactions in receptor heteromers. A working hypothesis. Curr Opin Pharmacol 10:14\u201322","journal-title":"Curr Opin Pharmacol"},{"key":"812_CR19","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0079-6123(06)60017-4","volume":"160","author":"A Galvan","year":"2007","unstructured":"Galvan A, Wichmann T (2007) GABAergic circuits in the basal ganglia and movement disorders. Prog Brain Res 160:287\u2013312","journal-title":"Prog Brain Res"},{"key":"812_CR20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0006-8993(88)91217-6","volume":"460","author":"CR Gerfen","year":"1998","unstructured":"Gerfen CR, Young WS 3rd (1998) Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res 460:161\u2013167","journal-title":"Brain Res"},{"key":"812_CR21","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.neuint.2010.03.001","volume":"56","author":"B Guly\u00e1s","year":"2010","unstructured":"Guly\u00e1s B, Brockschnieder D, Nag S, Pavlova E, K\u00e1sa P, Beliczai Z, L\u00e9gr\u00e1di A, Gulya K, Thiele A, Dyrks T, Halldin C (2010) The norepinephrine transporter (NET) radioligand (S, S)-[18F]FMeNER-D2 shows significant decreases in NET density in the human brain in Alzheimer\u2019s disease: a post-mortem autoradiographic study. Neurochem Int 56:789\u2013798","journal-title":"Neurochem Int"},{"key":"812_CR22","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neuint.2010.10.013","volume":"58","author":"B Guly\u00e1s","year":"2011","unstructured":"Guly\u00e1s B, Pavlova E, K\u00e1sa P, Gulya K, Bakota L, V\u00e1rszegi S, Keller E, Horv\u00e1th MC, Nag S, Hermecz I, Magyar K, Halldin C (2011) Activated MAO-B in the brain of Alzheimer patients, demonstrated by [11C]-l-deprenyl using whole hemisphere autoradiography. Neurochem Intl 58:60\u201368","journal-title":"Neurochem Intl"},{"key":"812_CR23","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0006-8993(96)01131-6","volume":"745","author":"H Hall","year":"1997","unstructured":"Hall H, Lundkvist C, Halldin C, Farde L, Pike VW, McCarron JA, Fletcher A, Cliffe IA, Barf T, Wikstr\u00f6m H, Sedvall G (1997) Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]WAY-100635. Brain Res 745:96\u2013108","journal-title":"Brain Res"},{"key":"812_CR24","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0969-8051(98)00053-5","volume":"25","author":"H Hall","year":"1998","unstructured":"Hall H, Halldin C, Farde L, Sedvall G (1998) Whole hemisphere autoradiography of the postmortem human brain. Nucl Med Biol 25:715\u2013719","journal-title":"Nucl Med Biol"},{"key":"812_CR25","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s004010051037","volume":"97","author":"H Heinsen","year":"1999","unstructured":"Heinsen H, Rub U, Bauer M, Ulmar G, Bethke B, Sch\u00fcler M, B\u00f6cker F, Eisenmenger W, G\u00f6tz M, Korr H, Schmitz C (1999) Nerve cell loss in the thalamic mediodorsal nucleus in Huntington\u2019s disease. Acta Neuropathol 97:613\u2013622","journal-title":"Acta Neuropathol"},{"key":"812_CR26","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.bmc.2006.10.038","volume":"15","author":"S Hintermann","year":"2007","unstructured":"Hintermann S, Vranesic I, Allgeier H, Br\u00fclisauer A, Hoyer D, Lemaire M, Moenius T, Urwyler S, Whitebread S, Gasparini F, Auberson YP (2007) ABP688, a novel selective and high affinity ligand for the labeling of mGlu5 receptors: identification, in vitro pharmacology, pharmacokinetic and biodistribution studies. Bioorg Med Chem 15:903\u2013914","journal-title":"Bioorg Med Chem"},{"key":"812_CR27","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1006\/nbdi.2002.0528","volume":"10","author":"V Macdonald","year":"2002","unstructured":"Macdonald V, Halliday G (2002) Pyramidal cell loss in motor cortices in Huntington\u2019s disease. Neurobiol Dis 10:378\u2013386","journal-title":"Neurobiol Dis"},{"key":"812_CR28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0006-8993(83)90003-3","volume":"289","author":"PE Marshall","year":"1983","unstructured":"Marshall PE, Landis DM, Zalneraitis EL (1983) Immunocytochemical studies of substance P and leucine-enkephalin in Huntington\u2019s disease. Brain Res 289:11\u201326","journal-title":"Brain Res"},{"key":"812_CR29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1242\/dev.116.1.201","volume":"116","author":"RJ Mullen","year":"1992","unstructured":"Mullen RJ, Buck CR, Smith AM (1992) NeuN, a neuronal specific nuclear protein in vertebrates. Development 116:201\u2013211","journal-title":"Development"},{"key":"812_CR30","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/00005072-199111000-00005","volume":"50","author":"RH Myers","year":"1991","unstructured":"Myers RH, Vonsattel JP, Paskevich PA, Kiely DK, Stevens TJ, Cupples LA, Richardson EP Jr, Bird ED (1991) Decreased neuronal and increased oligodendroglial densities in Huntington\u2019s disease caudate nucleus. J Neuropathol Exp Neurol 50:729\u2013742","journal-title":"J Neuropathol Exp Neurol"},{"key":"812_CR31","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1471-4159.2010.06635.x","volume":"113","author":"B Ouattara","year":"2010","unstructured":"Ouattara B, Gasparini F, Morissette M, Gr\u00e9goire L, Samadi P, Gomez-Mancilla B, Di Paolo T (2010) Effect of L-Dopa on metabotropic glutamate receptor 5 in the brain of parkinsonian monkeys. J Neurochem 113:715\u2013724","journal-title":"J Neurochem"},{"key":"812_CR32","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.neurobiolaging.2009.07.014","volume":"32","author":"B Ouattara","year":"2011","unstructured":"Ouattara B, Gregoire L, Morissette M, Gasparini F, Vranesic I, Bilbe G, Johns DR, Rajput A, Hornykiewicz O, Rajput AH, Gomez-Mancilla B, Di Paolo T (2011) Metabotropic glutamate receptor type 5 in levodopa-induced motor complications. Neurobiol Aging 32:1286\u20131295","journal-title":"Neurobiol Aging"},{"key":"812_CR33","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0893-133X(01)00256-1","volume":"25","author":"P Popoli","year":"2001","unstructured":"Popoli P, Pezzola A, Torvinen M, Reggio R, Pintor A, Scarchilli L, Fuxe K, Ferr\u00e9 S (2001) The selective mGlu(5) receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D(2) receptors in the rat striatum: interactions with adenosine A(2a) receptors. Neuropsychopharmacology 25:505\u2013513","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"812_CR34","doi-asserted-by":"crossref","first-page":"e14020","DOI":"10.1371\/journal.pone.0014020","volume":"5","author":"DL Price","year":"2010","unstructured":"Price DL, Rockenstein E, Ubhi K, Phung V, MacLean-Lewis N, Askay D, Cartier A, Spencer B, Patrick C, Desplats P, Ellisman MH, Masliah E (2010) Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy\u2014implications for excitotoxicity. PLoS One 5(11):e14020","journal-title":"PLoS One"},{"key":"812_CR35","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","volume":"85","author":"A Reiner","year":"1988","unstructured":"Reiner A, Albin RL, Anderson KD, D\u2019Amato CJ, Penney JB, Young AB (1988) Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci USA 85:5733\u20135737","journal-title":"Proc Natl Acad Sci USA"},{"key":"812_CR36","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1002\/mds.25624","volume":"28","author":"A Reiner","year":"2013","unstructured":"Reiner A, Shelby E, Wang H, Demarch Z, Deng Y, Guley NH, Hogg V, Roxburgh R, Tippett LJ, Waldvogel HJ, Faull RL (2013) Striatal parvalbuminergic neurons are lost in Huntington\u2019s disease: implications for dystonia. Mov Disord 28:1691\u20131699","journal-title":"Mov Disord"},{"key":"812_CR37","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1523\/JNEUROSCI.4974-09.2010","volume":"30","author":"FM Ribeiro","year":"2010","unstructured":"Ribeiro FM, Paquet M, Ferreira LT, Cregan T, Swan P, Cregan SP, Ferguson SS (2010) Metabotropic glutamate receptor-mediated cell signaling pathways are altered in a mouse model of Huntington\u2019s disease. J Neurosci 30:316\u2013324","journal-title":"J Neurosci"},{"key":"812_CR38","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0306-4522(94)00427-7","volume":"64","author":"E Sapp","year":"1995","unstructured":"Sapp E, Ge P, Aizawa H, Bird E, Penney J, Young AB, Vonsattel JP, DiFiglia M (1995) Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington\u2019s disease using high resolution image analysis. Neuroscience 64:397\u2013404","journal-title":"Neuroscience"},{"key":"812_CR39","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.brainres.2004.06.005","volume":"1019","author":"J Schiefer","year":"2004","unstructured":"Schiefer J, Spr\u00fcnken A, Puls C, L\u00fcesse HG, Milkereit A, Milkereit E, Johann V, Kosinski CM (2004) The metabotropic glutamate receptor 5 antagonist MPEP and the mGluR2 agonist LY379268 modify disease progression in a transgenic mouse model of Huntington\u2019s disease. Brain Res 1019:246\u2013254","journal-title":"Brain Res"},{"key":"812_CR40","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/cne.902970304","volume":"297","author":"LD Selemon","year":"1990","unstructured":"Selemon LD, Goldman-Rakic PS (1990) Topographic intermingling of striatonigral and striatopallidal neurons in the rhesus monkey. J Comp Neurol 297:359\u2013376","journal-title":"J Comp Neurol"},{"key":"812_CR41","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3109\/10520296909063364","volume":"44","author":"W Senior","year":"1969","unstructured":"Senior W (1969) Staining of animal tissues with the dye base of methylene green in benzene to facilitate identification and selection of material. Stain Technol 44:269\u2013271","journal-title":"Stain Technol"},{"key":"812_CR42","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/jnnp.56.5.487","volume":"56","author":"E Spargo","year":"1993","unstructured":"Spargo E, Everall IP, Lantos PL (1993) Neuronal loss in the hippocampus in Huntington\u2019s disease: a comparison with HIV infection. J Neurol Neurosurg Psychiatry 56:487\u2013491","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"812_CR43","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","volume":"57","author":"JP Vonsattel","year":"1998","unstructured":"Vonsattel JP, DiFiglia M (1998) Huntington disease. J Neuropathol Exp Neurol 57:369\u2013384","journal-title":"J Neuropathol Exp Neurol"},{"key":"812_CR44","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr (1985) Neuropathological classification of Huntington\u2019s disease. J Neuropathol Exp Neurol 44:559\u2013577","journal-title":"J Neuropathol Exp Neurol"},{"key":"812_CR45","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker FO (2007) Huntington\u2019s disease. Lancet 369:218\u2013228","journal-title":"Lancet"},{"key":"812_CR46","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0306-4522(88)90249-7","volume":"25","author":"CM Waters","year":"1988","unstructured":"Waters CM, Peck R, Rossor M, Reynolds GP, Hunt SP (1988) Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson\u2019s disease and Huntington\u2019s chorea. Neuroscience 25:419\u2013438","journal-title":"Neuroscience"}],"container-title":["Brain Structure and Function"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00429-014-0812-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00429-014-0812-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00429-014-0812-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T11:13:43Z","timestamp":1649502823000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00429-014-0812-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,28]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["812"],"URL":"https:\/\/doi.org\/10.1007\/s00429-014-0812-y","relation":{},"ISSN":["1863-2653","1863-2661"],"issn-type":[{"value":"1863-2653","type":"print"},{"value":"1863-2661","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,28]]}}}